Ihle et al. utilized a LysMCre-mediated myeloid-specific Bmpr1a conditional knockout mouse model along with a syngeneic prostate cancer model and demonstrated the pro-tumorigenic role of ALK3 in myeloid cells. This evidence concerns the gene BMPR1A and Familial prostate cancer.